13 May 2008
For Immediate Release
PLANT HEALTH CARE PLC (THE 'COMPANY')
Directors' dealings and additional listing
On 12 May 2008, pursuant to the exercise of options by John Brady, Chief Executive, the Company approved the allotment and issue credited as fully paid of 50,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares'), details as follows:
Name of option holder |
Number of shares over which option exercised |
Option price per share |
John A. Brady |
50,000 |
37p |
The Company was subsequently advised that, on 12 May 2008, John Brady sold 50,000 Ordinary Shares at a price of 340 pence per share.
The Company was also advised on 12 May 2008 that Dr. Albert Fischer, Chairman, sold 25,000 Ordinary Shares at a price of 340 pence per share.
Following the above-mentioned allotment and disposals, the interests of Dr. Albert Fischer and John Brady in the ordinary share capital of the Company are as shown below:
Name |
Ordinary Share holding |
Percentage of issued Ordinary Share capital |
Share Options |
LTIPs |
Dr. Albert Fischer |
129,736 |
0.29% |
225,000 |
Nil |
John Brady |
14,395 |
0.032% |
1,150,000 |
200,000 |
Application has been made for 50,000 Ordinary Shares (the 'New Shares') to be admitted to trading on the London Stock Exchange's AIM market for listed securities ('Admission').
The New Shares are being issued pursuant to the exercise of options. Admission is expected to become effective on 19 May 2008. The New Shares will rank pari passu with the Company's existing Ordinary Shares.
Following admission of the New Shares, the total issued share capital of the Company will be 44,801,798 Ordinary Shares, all of which have voting rights.
The above figure 44,801,798 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.
Enquiries:
Andrew C. Wood FCIS |
Company Secretary |
020 8866 5702 |
Evolution Securities Limited |
Tim Worlledge/Tim Redfern |
Tel: 020 7071 4300 |
Tavistock Communications |
Jeremy Carey/Matt Ridsdale |
Tel: 020 7920 3150 |
END